Oncternal Therapeutics Inc. (ONCT) Fundamentals

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that targets ROR1 and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers.
SHARE INFORMATION
Market CapUS$ 51.900.507
Shares Outstanding49.429.054
Float48.912.734
Percent Float98,96%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0,64
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions190
Institutional Holdings Date2022-06-30
Institutional Bought Previous 3 Months1.129.933
Institutional Holdings Percent49,2%
Institutional Sold Previous 3 Months3.565.660
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months5.000
Insider Holdings Percent29,3
Insider Sold Previous 3 Months-
Insider Shares Owned14.465.752
TRADING INFO
52 Week HighUS$ 4,69
52 Week LowUS$ 0,69
52 Week High ChangeUS$ -77,27
21 Day Moving AverageUS$ 1,2214
21 Day Extended Moving AverageUS$ 1,1521
50 Day Moving AverageUS$ 1,0836
50 Day Extended Moving AverageUS$ 1,1863
200 Day Moving AverageUS$ 2,2093
200 Day Extended Moving AverageUS$ 2,1089
10 Day Average Volume902.840
20 Day Average Volume748.602
30 Day Average Volume1.721.087
50 Day Average Volume1.203.489
Alpha-0.012548
Beta1.7490
Standard Deviation0.294501
R20.084283
7 Day Price ChangeUS$ -0,12
7 Day Percent Change-10,26%
21 Day Price ChangeUS$ -0,10
21 Day Percent Change-8,7%
30 Day Price ChangeUS$ -0,47
30 Day Percent Change-30,92%
Month to Date Price ChangeUS$ -0,06
Month to Date Percent Change-5,41%
Quarter to Date Price ChangeUS$ -0,06
Quarter to Date Percent Change-5,41%
180 Day Price ChangeUS$ -1,23
180 Day Percent Change-53,95%
200 Day Price ChangeUS$ -1,66
200 Day Percent Change-61,25%
Year to Date Price ChangeUS$ -1,22
Year to Date Percent Change-53,74%

Oncternal Therapeutics Inc. (ONCT) Key Ratios

PROFITABILITY
EBIT Margin-818,5%
EBITDA Margin-818,5%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book0,60
Total Debt To Equity0,00
Int Coverage0,00
Current Ratio16,10
Leverage Ratio1,10
Quick Ratio15,50
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio-1,40
Enterprise ValueUS$ -30.721.784
Price to Sales0,00
Price to Free Cash-2,40
PE High Last 5 Years-1,40
Price To Book0,60
Price To Cash Flow0,00
PE Low Last 5 Years-2,60
Price to Tangible Book0,60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-36,53
Return on Equity-38,68
Return on Capital-37,43

Oncternal Therapeutics Inc. (ONCT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOJames B. Breitmeyer
Emplyoees29
Last AuditUQ
CIK0001260990
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12230 El Camino Real
Suite 300
San Diego, CA 92130
Websitehttps://www.oncternal.com
Facsimile+1 858 408-3010
Telephone+1 858 434-1113
Emailrvincent@oncternal.com
Seu Histórico Recente
NASDAQ
ONCT
Oncternal ..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220707 13:12:52